Summary Hyperthyroidism is a rare side effect of amiodarone treatment.
Introduction
Amiodarone is an iodine-containing drug, similar to thyroxine. It was found to be effective in the treatment of angina pectoris and as an antiarrhythmic agent. Side effects are few, the most common ofwhich is the appearance of microdeposits in the cornea; photodermatitis, hypothyroidism and, rarely, hyperthyroidism have been reported. Four patients with hyperthyroidism due to treatment with amiodarone are described and the literature is reviewed.
Case reports Case 1
A 68-year-old woman suffering from ischaemic heart disease of 4 months' duration, had been referred complaining of palpitations which proved to be due to paroxysms of atrial fibrillation. Attempts to treat this with digoxin, propranolol, quinidine, procainamide and disopyramide failed and a regimen of 600 mg amiodarone daily was instituted and after 2 weeks reduced to 400 mg/day for the next 6 months. This treatment was successful, without recurrence of any symptom. Plasma thyroxine (T4) before treatment was 11-8 tig/dl (normal, 4-5-11-5) . After 6 months the patient complained of increased irritability, sweating, diarrhoea and a loss of 9 kg in weight despite a normal appetite. Physical examination revealed no exophthalmos or goitre. Thyroid function tests showed: plasma T4, 18 ,ug/dl; T3 uptake-45-3% (normal: 30-40) and free thyroxine index (FTI), 23-1 (normal: 5-11). Amiodarone was discontinued and the patient was treated with a variety ofantithyroid drugs which, because they caused severe leucopenia, were stopped. It has to be noted that since amiodarone was discontinued the patient has not relapsed into atrial fibrillation. After 6 months plasma T4 is still elevated at 16-1 ,ug/dl. Amiodarone accumulates mainly in muscle and adipose tissue during the first month of intake of 400 mg daily, which is the regular dose, following which a steady state ensues. The metabolism of the drug yields about 9 mg of iodine/day, which is 100 times the normal dietary intake. The half-life of amiodarone in the body is between 28-100 days according to different authors (Broekuysen, Caruel and Sion, 1969; Massin et al., 1971) . However in some cases the drug has been known to be active 11 months after it was discontinued. Prichard, Bramah and Hurley (1975) Hypothyroidism following amiodarone has been described in a few patients (Massin et al., 1971; Hazard et al., 1973; Rosenbaum et al., 1976) . Hyperthyroidism, on the other hand, has not been frequently reported (Jonckheer et al., 1973; Chapelle, Naouri and Wolff, 1976; Heraud et al., 1974; Riviere et al., 1974) . Rosenbaum et al. (1976) The second group included patients without any past thyroid disease, who had discontinued taking amiodarone for at least 3 months before the appearance of signs of hyperthyroidism. The hyperthyroidism was of the kind created by an overdosage of thyroxine.
The third group, consisted of those patients who did not have any past records of thyroid malfunction and who developed, during treatment with amiodarone, thyrotoxic symptoms. This is probably the largest group and has also been described by others (Chapelle et al., 1976; Heraud et al., 1974; Rivibre et al., 1974; Savoie et al., 1975) ; it is exemplified by the last 3 patients in the present series. The patients described by Savoie et al. (1975) 
